This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 1.22% to $1.62 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.67% to 23,025.59 and the Dow Jones Industrial Average  rising 1.43% to 47,112.45.
This was the stock's third consecutive day of losses.
TherapeuticsMD Inc. closed 33.61% below its 52-week high of $2.44, which the company reached on January 3rd.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) rose 1.00% to $231.80.
Trading volume (26,157) remained 245,984 below its 50-day average volume of 272,141.
Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-25-25 1731ET

TXMD

ABBV

<p>TherapeuticsMD Inc. (TXMD) shares fell 1.22% to $1.62 on Tuesday, underperforming compared to competitors like AbbVie Inc. (ABBV), which rose 1.00%. This marks the third consecutive day of losses for TXMD, closing 33.61% below its 52-week high. Trading volume was significantly below the 50-day average.</p>

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors